© 2017 Evestra, Inc.


Evestra, Inc. celebrated the completion of its move to new headquarters and manufacturing facilities, the re-election of its board of directors, and the conversion of Gedeon Richter Plc.’s $5 million loan to an equity position in the company.

Evestra also marked the 10th anniversary of its incorporation as a spinoff from the Texas Biomedical Research Institute, based on that organization’s organic chemistry research over several decades.

“We’re excited about the future,” said Evestra President and CEO Ze’ev Shaked. “We have an innovative product pipeline based on two enabling platform technologies, a manufacturing operation in support of our products, excellent partners in Gedeon Richter and Glenmark Pharmaceuticals, 28 outstanding employees, and operations in three countries – the U.S., Germany, and Poland.”